Guselkumab for checkpoint inhibitor-exacerbated psoriasis in a patient with metastatic melanoma.
Conlon O, Herlihy M, Safta Y, Goh Y, Reilly A, Murphy A, O'Kane M
Clinical and Experimental DermatologyIn the feed 6 Jul 2026, published online 6 Jul 2026, issue 2026 Jul 06, added to PubMed 6 Jul 2026
Topics: Skin cancer & tumorsMelanoma & molesPsoriasisBiologicsCancer drugs
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42403109 · DOI 10.1093/ced/llag280